title: Emerging microsporidian infections in Russian HIV-infected patients.
abstract: Microsporidia were identified in stool specimens by histochemistry and PCR of 30 (18.9%) of 159 HIV-infected patients presenting to the S. P. Botkin Memorial Clinical Hospital of Infectious Diseases, St. Petersburg, Russia. The higher prevalence of Encephalitozoon intestinalis, in 21 (12.8%) patients, than of Enterocytozoon bieneusi, in 2 patients (1.2%), was unexpected. Encephalitozoon cuniculi was detected in three patients: one with strain I and two with strain II. Encephalitozoon hellem was detected in one patient, and two patients were identified as being infected by Microsporidium species. One patient was infected with both E. intestinalis and E. cuniculi. In two patients, the microsporidian species were not identifiable. No statistically significant differences in gender, age, and stage of AIDS were observed between the microsporidian-positive and -negative HIV-infected patients. HIV-infected patients diagnosed with microsporidian infection, however, were significantly more likely to exhibit ≤ 100 CD4(+) T cells/μl blood (20/30 patients [67%]; odds ratio [OR], 3.150; 95% confidence interval [CI(95)], 1.280 to 7.750; P = 0.0116) and weight loss of >10% of the baseline (19/30 patients [63%]; odds ratio, 2.995; CI(95), 1.100 to 8.158; P = 0.0352) than HIV-infected patients not diagnosed with microsporidian infection. In summary, this is the first report describing the diagnosis of microsporidian infection of HIV-infected patients in Russia and the first detection of E. cuniculi strain II in a human.
authors: Departments of Infectious Disease, Cleveland Clinic, Cleveland, Ohio 44195, USA. esdnda@tulane.edu
authors: Olga I
authors: OI
authors: Sokolova
authors: Anton V
authors: AV
authors: Demyanov
authors: Lisa C
authors: LC
authors: Bowers
authors: Elizabeth S
authors: ES
authors: Didier
authors: Alexei V
authors: AV
authors: Yakovlev
authors: Sergei O
authors: SO
authors: Skarlato
authors: Yuliya Y
authors: YY
authors: Sokolova
mesh_terms: D000328:Adult; D021821:Communicable Diseases, Emerging / Q000453:epidemiology* / Q000382:microbiology; D004271:DNA, Fungal / Q000737:chemistry / Q000235:genetics; D021903:DNA, Ribosomal Spacer / Q000737:chemistry / Q000235:genetics; D021862:Enterocytozoon / Q000145:classification / Q000302:isolation & purification*; D005243:Feces / Q000382:microbiology; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006651:Histocytochemistry / Q000379:methods; D006801:Humans; D008297:Male; D021861:Microsporidia, Unclassified / Q000145:classification / Q000302:isolation & purification*; D016881:Microsporidiosis / Q000453:epidemiology* / Q000382:microbiology; D008875:Middle Aged; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction / Q000379:methods; D012426:Russia / Q000453:epidemiology; D017422:Sequence Analysis, DNA
chemical_list: D004271:DNA, Fungal; D021903:DNA, Ribosomal Spacer